ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,847Medicare Part D Prescriptions Filled, Including Refills

Rank: 449 out of 3734

$843K Total Retail Price of All Prescriptions

Rank: 188 out of 3734

369 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 369 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 369 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 4,579 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OXYCODONE HCL 434 0 S2 1 58
HYDROCODONE-ACETAMINOPHEN 425 95 S3 2 12
SIMVASTATIN 359 179 3 1
OMEPRAZOLE 317 158 4 4
LEVOTHYROXINE SODIUM 281 111 5 2
FUROSEMIDE 219 124 6 7
METFORMIN HCL 215 124 7 8
METOPROLOL TARTRATE 175 124 8 6
AMLODIPINE BESYLATE 175 129 8 5
LISINOPRIL 161 88 10 3
CARISOPRODOL 161 29 R 10 134
WARFARIN SODIUM 155 116 12 10
HYDROCHLOROTHIAZIDE 150 100 13 9
CYMBALTA 146 41 14 67
ATORVASTATIN CALCIUM 143 98 15 11
ZOLPIDEM TARTRATE 141 46 16 24
SERTRALINE HCL 139 82 17 18
AZITHROMYCIN 116 30 18 38
PREDNISONE 115 48 19 42
TRAMADOL HCL 113 54 20 20
MIRTAZAPINE 108 72 21 45
VENTOLIN HFA 106 19 22 70
GABAPENTIN 98 43 23 17
OXYCONTIN 94 13 S2 24 121
OXYCODONE HCL-ACETAMINOPHEN 92 11 S2 25 122
ADVAIR DISKUS 89 38 26 35
AMITRIPTYLINE HCL 88 34 R 27 94
FENTANYL 87 0 S2 28 65
SPIRIVA 86 22 29 40
CITALOPRAM HBR 86 22 29 16
FLUTICASONE PROPIONATE 83 40 31 46
CIPROFLOXACIN HCL 79 45 32 77
FLUOXETINE HCL 77 39 33 61
OXYCODONE-ACETAMINOPHEN 76 0 S2 34 51
BUPROPION HCL SR 71 0 35 165
LEVEMIR FLEXPEN 69 31 36 184
CELEBREX 69 52 36 69
CLOPIDOGREL 68 40 38 23
BUSPIRONE HCL 67 46 39 129
METOPROLOL SUCCINATE 65 60 40 14
VALACYCLOVIR 63 21 41 521
KLOR-CON M20 63 34 41 48
LAMOTRIGINE 62 32 43 169
PEN NEEDLE 62 29 43 152
SYNTHROID 61 41 45 47
MELOXICAM 59 24 46 52
POTASSIUM CHLORIDE 57 37 47 19
DEXTROAMPHETAMINE-AMPHETAMINE 57 0 S2 47 544
TOPIRAMATE 55 19 49 181
FENOFIBRATE 55 17 49 81
GLIMEPIRIDE 54 41 51 37
MORPHINE SULFATE ER 54 0 S2 51 104
ROPINIROLE HCL 53 0 53 118
LORAZEPAM 53 17 53 210
TRIAMTERENE-HCTZ 52 18 55 73
ZOLPIDEM TARTRATE ER 51 29 56 474
DIOVAN 50 47 57 31
METHADONE HCL 50 0 S2 57 193
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.